BioPlus Acquisition Corp.
BIOS · NASDAQ
12/31/2022 | 12/31/2021 | 12/31/2018 | 12/31/2017 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $1,996 | -$0 | -$51,700 | -$64,200 |
| Dep. & Amort. | $0 | $0 | $23,600 | $27,730 |
| Deferred Tax | $0 | $0 | $70 | -$3,380 |
| Stock-Based Comp. | $0 | $0 | $0 | $0 |
| Change in WC | $480 | $0 | -$66,577 | -$15,200 |
| Other Non-Cash | -$3,167 | -$1 | $70,332 | $51,930 |
| Operating Cash Flow | -$691 | -$1 | -$20,100 | -$760 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | -$13,880 | -$8,680 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | -$256 | $360 | -$4,950 |
| Investing Cash Flow | $0 | -$256 | -$13,520 | -$13,630 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $0 | $0 | $0 | $20,777 |
| Stock Repurch. | $0 | $0 | -$60 | $20,900 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $196 | $257 | $8,070 | $44,280 |
| Financing Cash Flow | $196 | $257 | $8,070 | $44,280 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$495 | $1 | -$25,550 | $29,890 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $636 | $0 | $39,500 | $9,600 |
| End Cash | $140 | $1 | $13,950 | $39,490 |
| Free Cash Flow | -$691 | -$1 | -$33,980 | -$9,440 |